| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1381 | 2018 |
| Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. M Stumvoll, A Mitrakou, W Pimenta, T Jenssen, H Yki-Järvinen, ... Diabetes care 23 (3), 295-301, 2000 | 1369 | 2000 |
| Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance A Mitrakou, D Kelley, M Mokan, T Veneman, T Pangburn, J Reilly, ... New England Journal of Medicine 326 (1), 22-29, 1992 | 844 | 1992 |
| Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction A Mitrakou, C Ryan, T Veneman, M Mokan, T Jenssen, I Kiss, J Durrant, ... American Journal of Physiology-Endocrinology And Metabolism 260 (1), E67-E74, 1991 | 791 | 1991 |
| Oxidative stress biomarkers responses to physical overtraining: implications for diagnosis K Margonis, IG Fatouros, AZ Jamurtas, MG Nikolaidis, I Douroudos, ... Free Radical Biology and Medicine 43 (6), 901-910, 2007 | 506 | 2007 |
| Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population A Gastaldelli, M Kozakova, K Højlund, A Flyvbjerg, A Favuzzi, A Mitrakou, ... Hepatology 49 (5), 1537-1544, 2009 | 491 | 2009 |
| Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative W Pimenta, M Korytkowski, A Mitrakou, T Jenssen, H Yki-Jarvinen, ... Jama 273 (23), 1855-1861, 1995 | 487 | 1995 |
| Treatment modalities of obesity: what fits whom? V Hainer, H Toplak, A Mitrakou Diabetes care 31 (Supplement_2), S269-S277, 2008 | 479 | 2008 |
| Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM A Mitrakou, D Kelley, T Veneman, T Jenssen, T Pangburn, J Reilly, ... Diabetes 39 (11), 1381-1390, 1990 | 443 | 1990 |
| Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. D Kelley, A Mitrakou, H Marsh, F Schwenk, J Benn, G Sonnenberg, ... The Journal of clinical investigation 81 (5), 1563-1571, 1988 | 386 | 1988 |
| Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans C Meyer, W Pimenta, HJ Woerle, T Van Haeften, E Szoke, A Mitrakou, ... Diabetes care 29 (8), 1909-1914, 2006 | 380 | 2006 |
| Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related IG Fatouros, S Tournis, D Leontsini, AZ Jamurtas, M Sxina, P Thomakos, ... The Journal of Clinical Endocrinology & Metabolism 90 (11), 5970-5977, 2005 | 380 | 2005 |
| Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. C Meyer, M Stumvoll, V Nadkarni, J Dostou, A Mitrakou, J Gerich The Journal of clinical investigation 102 (3), 619-624, 1998 | 372 | 1998 |
| Renal glucose production and utilization: new aspects in humans M Stumvoll, C Meyer, A Mitrakou, V Nadkarni, JE Gerich Diabetologia 40, 749-757, 1997 | 329 | 1997 |
| Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia T Veneman, A Mitrakou, M Mokan, P Cryer, J Gerich Diabetes 42 (9), 1233-1237, 1993 | 293 | 1993 |
| Hypoglycemia unawareness JE Gerich, M Mokan, T Veneman, M Korytkowski, A Mitrakou Endocrine reviews 12 (4), 356-371, 1991 | 281 | 1991 |
| Effect of aging on glucose homeostasis: accelerated deterioration of β-cell function in individuals with impaired glucose tolerance E Szoke, MZ Shrayyef, S Messing, HJ Woerle, TW Van Haeften, C Meyer, ... Diabetes care 31 (3), 539-543, 2008 | 269 | 2008 |
| Reversibility of unawareness of hypoglycemia in patients with insulinomas A Mitrakou, C Fanelli, T Veneman, G Perriello, S Calderone, ... New England Journal of Medicine 329 (12), 834-839, 1993 | 268 | 1993 |
| Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values HJ Woerle, WP Pimenta, C Meyer, NR Gosmanov, E Szoke, T Szombathy, ... Archives of Internal Medicine 164 (15), 1627-1632, 2004 | 205 | 2004 |
| The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome E Diamanti-Kandarakis, A Mitrakou, S Raptis, G Tolis, AJ Duleba The Journal of Clinical Endocrinology & Metabolism 83 (8), 2699-2705, 1998 | 200 | 1998 |
